Literature DB >> 10389090

Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil.

C M Ellis1, C Monk, A Simmons, G Lemmens, S C Williams, M Brammer, E Bullmore, J D Parkes.   

Abstract

Functional magnetic resonance imaging (fMRI) can be used to detect regional brain responses to changes in sensory stimuli. We have used fMRI to determine the amount of visual and auditory cortical activation in 12 normal subjects and 12 subjects with the narcoleptic syndrome, using a multiplexed visual and auditory stimulation paradigm. In both normal and narcoleptic subjects, mean cortical activation levels during the presentation of periodic visual and auditory stimulation showed no appreciable differences with either age or sex. Normal subjects showed higher levels of visual activation at 10:00 hours than 15:00 hours, with a reverse pattern in narcoleptic subjects (P = 0.007). The group differences in spatial extent of cortical activation between control and narcoleptic subjects were small and statistically insignificant. The alerting action, and imaging response, to a single oral dose of the sleep-preventing drug modafinil 400 mg were then determined and compared with placebo in both the 12 normal (8 given modafinil, 4 placebo) and 12 narcoleptic subjects (8 modafinil, 4 placebo). Modafinil caused an increase in self-reported levels of alertness in 7 of 8 narcoleptic subjects, but there was no significant difference between mean pretreatment and post-treatment activation levels as determined by fMRI for either normal or narcoleptic syndrome subjects given modafinil. However, in the modafinil-treated group of 8 normal and 8 narcoleptic subjects, there was a clock time independent correlation between the initial level of activation as determined by the pretreatment scan and the post-treatment change in activation (visual, P = 0.002; and auditory, P = 0.001). No correlation was observed in placebo-treated subjects (P = 0.99 and 0.77, respectively). Although limited by the small number of subjects, and the lack of an objective measure of alertness, the findings of this study suggest that low cortical activation levels in both normal and narcoleptic subjects are increased following the administration of modafinil. Functional magnetic resonance imaging may be a valuable addition to established studies of attention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389090     DOI: 10.1046/j.1365-2869.1999.00142.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  10 in total

1.  EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.

Authors:  M Saletu; P Anderer; G M Saletu-Zyhlarz; M Mandl; O Arnold; J Zeitlhofer; B Saletu
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

2.  Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers.

Authors:  E R Samuels; R H Hou; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2006-06-27       Impact factor: 4.530

3.  Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers.

Authors:  R H Hou; C Freeman; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

4.  The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with sleep apnea.

Authors:  Alexandra Nikolaou; Sophia E Schiza; Stella G Giakoumaki; Panos Roussos; Nikolaos Siafakas; Panos Bitsios
Journal:  Psychopharmacology (Berl)       Date:  2007-09-25       Impact factor: 4.530

5.  Effects of modafinil on working memory processes in humans.

Authors:  Ulrich Müller; Nikolai Steffenhagen; Ralf Regenthal; Peter Bublak
Journal:  Psychopharmacology (Berl)       Date:  2004-06-24       Impact factor: 4.530

Review 6.  Neuroimaging insights into the pathophysiology of sleep disorders.

Authors:  Martin Desseilles; Thanh Dang-Vu; Manuel Schabus; Virginie Sterpenich; Pierre Maquet; Sophie Schwartz
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

7.  A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Thomas Rugino
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

8.  Mechanisms of modafinil: A review of current research.

Authors:  Paul Gerrard; Robert Malcolm
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

Review 9.  Functional magnetic resonance imaging in narcolepsy and the kleine-levin syndrome.

Authors:  Maria Engström; Tove Hallböök; Attila Szakacs; Thomas Karlsson; Anne-Marie Landtblom
Journal:  Front Neurol       Date:  2014-06-25       Impact factor: 4.003

10.  Cortico-Amygdala-Striatal Activation by Modafinil/Flecainide Combination.

Authors:  Dominique Vodovar; Adeline Duchêne; Catriona Wimberley; Claire Leroy; Géraldine Pottier; Yves Dauvilliers; Christian Giaume; Jian-Sheng Lin; Franck Mouthon; Nicolas Tournier; Mathieu Charvériat
Journal:  Int J Neuropsychopharmacol       Date:  2018-07-01       Impact factor: 5.176

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.